Product NDC: | 17478-107 |
Proprietary Name: | Levofloxacin |
Non Proprietary Name: | Levofloxacin |
Active Ingredient(s): | 25 mg/mL & nbsp; Levofloxacin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17478-107 |
Labeler Name: | Akorn, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091644 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110701 |
Package NDC: | 17478-107-20 |
Package Description: | 1 VIAL in 1 CARTON (17478-107-20) > 20 mL in 1 VIAL |
NDC Code | 17478-107-20 |
Proprietary Name | Levofloxacin |
Package Description | 1 VIAL in 1 CARTON (17478-107-20) > 20 mL in 1 VIAL |
Product NDC | 17478-107 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levofloxacin |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110701 |
Marketing Category Name | ANDA |
Labeler Name | Akorn, Inc. |
Substance Name | LEVOFLOXACIN |
Strength Number | 25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |